Frankfurt/Main (Germany), 16th January 2008. IonGate Biosciences GmbH announces the closing of the third allotment round. The basic addition of the investors Heidelberg Innovation and KfW (Kreditanstalt für Wiederaufbau) therewith amounts to €4.6 actor in 2007. IonGate will use the access in basic to aggrandize its all-embracing business activities, for the common commercialization of the SURFE2R Technology (SURFace Electrogenic Event Reader) and for the added development of the SURFE2R Workstation.
In December 2007 IonGate accomplished a absolute footfall appear internationalization with the accumulation of IonGate Biosciences Incorporated in New York, USA. The wholly endemic accessory is the aboriginal adopted accessory of the Germany-based company. IonGate Biosciences Inc. will actively abetment the all-embracing business of the SURFE2R Technology, decidedly in the North American area. The aloft funds will be partly acclimated to authorize the appropriate administration channels aural the USA. The accumulation of the American accessory supports IonGate to accommodated the accretion appeal for adult techniques to automatically appraisal electrogenic film proteins with its SURFE2R Technology.
Furthermore, the invested basic will ammunition the connected development of the SURFE2R Workstation, activated for a absolute anatomic assuming of carriage proteins. This technology platform, which is abnormally advised for biologic biologic screening, is the alone accessible arrangement so far to automatically awning for advance structures in a fast and cost-efficient appearance with top throughput. The SURFE2R Workstation 8 will addition these processes already added and accredit alongside measurements. Thus, IonGate provides the biologic industry with a proprietary technology for a awful able development of new agents.
Wolfgang Lerch
Managing Director
IonGate Biosciences GmbH
Industriepark Hoechst / Building D528
65926 Frankfurt/Main
Germany
phone+49.69.305.85 400
fax +49.69.305.85 444
email info@iongate.net
Wolfgang Lerch
President
IonGate Biosciences Inc.
75 Broad Street, 21st Floor
New York, New York 10004
U.S.A.
phone +1.646.405.10 26
fax +1.646.405.10 27
email info@iongate.net
Media inquiries
Dr. Holger Bengs
Biotech Consulting
phone +49.69.619.94 273
fax +49.69.619.94 249
email info@holgerbengs.de
About IonGate Biosciences GmbH
IonGate Biosciences GmbH develops, produces and markets avant-garde screening technologies to investigate transporters and is the common arch aggregation in this area.
Transporters are capital for the metabolic functions of the cell, advice proc¬essing in the absolute animal and play a axiological role to the bloom of humans. Due to their difficult beginning accessibility transporters are underrepresented in accepted biologic screening processes so far. For the aboriginal time IonGate provides with SURFE2R One and SURFE2R Workstation a awful absolute anatomic screening of transporters in college throughput and thereby positions itself as a able accomplice for the biologic industry. With its SURFE2R Workstation IonGate has created a abstruse base for an automated and able-bodied analytic technique. The aggregation food complete solutions, besides disposables and reagents, this mainly com¬prises alone consulting casework absolute the architecture of customized applica¬tions.
IonGate Biosciences GmbH is a adventure basic financed biotechnology aggregation amid in Frankfurt/Main in Germany. In accession to the capital financier and arch accomplice Heidelberg Innovation the KfW holds a pale in IonGate. The aggregation was accustomed in 2000 and currently employs added than 30 agents members.
2009年12月16日星期三
Dr. Holger Bengs Biotech Consulting - IonGate starts commercialization of SURFE2R in Asia
Frankfurt/Main, Germany, March 12, 2008. IonGate Biosciences is accretion its operations to bazaar the SURFE2R (SURFace Electrogenic Event Reader) Technology to the Japanese market. BRC - Bio Research Center Co. Ltd Nagoya, Japan and IonGate accordingly acquaint the proprietary address to automatically awning carriage proteins in top throughput at affairs in Japan, appropriately authoritative the technology accessible to the Asian market.
BRC is an accustomed accomplice able to accumulation Japan’s advisers with Life-Sciences innovations from about the world. The administration of SURFE2R will advice defended its position as a able provider of adult technologies.
IonGate has auspiciously launched SURFE2R Technology in both Europe and North America, and expects a growing appeal for the technology in these markets. As Japanese scientists accomplish added adult analysis in the acreage of film proteins, abnormally on carriage proteins, the addition of the SURFE2R Technology is awful anticipated. This is the aboriginal footfall for accretion attendance in the Asian bazaar in 2008, one of the arch growing biotech markets worldwide.
The flagship archetypal of the artefact family, SURFE2R Workstation 500, will be showcased at two accurate affairs in Japan in March.
IonGate in Japan:
March 17 – 19, 200881st Annual affair of the Japanese Pharmacological Society, Yokohama
(Booth No. 22)
March 25 – 27, 200885th Annual Meeting of the Physiological Society of Japan, Tokyo
Contact IonGate Biosciences
Wolfgang Lerch
Managing Director
IonGate Biosciences GmbH
Industriepark Hoechst / Building D528
65926 Frankfurt/Main
Germany
phone+49.69.305.85 400
fax +49.69.305.85 444
email info@iongate.net
Wolfgang Lerch
President
IonGate Biosciences Inc.
25 Bradley Drive
Westbrook, Maine 04092-2013
U.S.A.
phone +1.646.405.1026
fax +1.646.405.1027
email info@iongate.net
Contact BRC
Mitsuhiro Edamura
Bio Research Center Co. Ltd.
4F Yokota Bldg. 2-28-24 Izumi
Higashi-ku, Nagoya 461-0001
Japan
phone+81.52.932 6421
fax+81.52.932 6755
emailsales@brck.co.jp
Media inquiries
Dr. Holger Bengs
Biotech Consulting
phone +49.69.619.94 273
fax +49.69.619.94 249
email info@holgerbengs.de
About IonGate Biosciences GmbH
IonGate Biosciences GmbH develops, produces and markets avant-garde screening technologies to investigate transporters and is the common arch aggregation in this area.
Transporters are capital for the metabolic functions of the cell, advice proc¬essing in the absolute organism, and aswell play a axiological role in the bloom of humans. Due to their difficult beginning accessibility transporters are under¬represented in accepted biologic screening processes to date. For the aboriginal time, IonGate’s SURFE2R One and SURFE2R Workstation 500 accommodate awful absolute anatomic screening of transporters in higher-throughput and appropriately positions itself as a arch accomplice for the biologic industry. With its SURFE2R Workstation 500 IonGate has created a abstruse base for an automated and able-bodied analytic technique. The aggregation provides absolute arrangement solutions, encompassing disposables and reagents, as able-bodied as alone consulting casework which cover the architecture of customized applications.
IonGate Biosciences GmbH is a adventure basic financed biotechnology aggregation amid in Frankfurt/Main, Germany and Portland, Maine, USA. In accession to the capital financier and arch accomplice Heidelberg Innovation the KfW holds a pale in IonGate. The aggregation was accustomed in 2000 and currently employs added than 30 agents members.
About Bio Research Co., Ltd.
BRC - Bio Research Center Co., Ltd. is a absolute supplier for analysis laboratories in universities and biologic industry in Japan. BRC assuredly searches for avant-garde technologies to accommodate its barter with accompaniment of the art articles from about the world. The aggregation was accustomed in 1984 and is amid in Nagoya, Japan with offices in Tokyo, Osaka and Fukuoka. Two accessory companies are anchored in the USA and in China. The aggregation currently employs 25 agents members.
BRC is an accustomed accomplice able to accumulation Japan’s advisers with Life-Sciences innovations from about the world. The administration of SURFE2R will advice defended its position as a able provider of adult technologies.
IonGate has auspiciously launched SURFE2R Technology in both Europe and North America, and expects a growing appeal for the technology in these markets. As Japanese scientists accomplish added adult analysis in the acreage of film proteins, abnormally on carriage proteins, the addition of the SURFE2R Technology is awful anticipated. This is the aboriginal footfall for accretion attendance in the Asian bazaar in 2008, one of the arch growing biotech markets worldwide.
The flagship archetypal of the artefact family, SURFE2R Workstation 500, will be showcased at two accurate affairs in Japan in March.
IonGate in Japan:
March 17 – 19, 200881st Annual affair of the Japanese Pharmacological Society, Yokohama
(Booth No. 22)
March 25 – 27, 200885th Annual Meeting of the Physiological Society of Japan, Tokyo
Contact IonGate Biosciences
Wolfgang Lerch
Managing Director
IonGate Biosciences GmbH
Industriepark Hoechst / Building D528
65926 Frankfurt/Main
Germany
phone+49.69.305.85 400
fax +49.69.305.85 444
email info@iongate.net
Wolfgang Lerch
President
IonGate Biosciences Inc.
25 Bradley Drive
Westbrook, Maine 04092-2013
U.S.A.
phone +1.646.405.1026
fax +1.646.405.1027
email info@iongate.net
Contact BRC
Mitsuhiro Edamura
Bio Research Center Co. Ltd.
4F Yokota Bldg. 2-28-24 Izumi
Higashi-ku, Nagoya 461-0001
Japan
phone+81.52.932 6421
fax+81.52.932 6755
emailsales@brck.co.jp
Media inquiries
Dr. Holger Bengs
Biotech Consulting
phone +49.69.619.94 273
fax +49.69.619.94 249
email info@holgerbengs.de
About IonGate Biosciences GmbH
IonGate Biosciences GmbH develops, produces and markets avant-garde screening technologies to investigate transporters and is the common arch aggregation in this area.
Transporters are capital for the metabolic functions of the cell, advice proc¬essing in the absolute organism, and aswell play a axiological role in the bloom of humans. Due to their difficult beginning accessibility transporters are under¬represented in accepted biologic screening processes to date. For the aboriginal time, IonGate’s SURFE2R One and SURFE2R Workstation 500 accommodate awful absolute anatomic screening of transporters in higher-throughput and appropriately positions itself as a arch accomplice for the biologic industry. With its SURFE2R Workstation 500 IonGate has created a abstruse base for an automated and able-bodied analytic technique. The aggregation provides absolute arrangement solutions, encompassing disposables and reagents, as able-bodied as alone consulting casework which cover the architecture of customized applications.
IonGate Biosciences GmbH is a adventure basic financed biotechnology aggregation amid in Frankfurt/Main, Germany and Portland, Maine, USA. In accession to the capital financier and arch accomplice Heidelberg Innovation the KfW holds a pale in IonGate. The aggregation was accustomed in 2000 and currently employs added than 30 agents members.
About Bio Research Co., Ltd.
BRC - Bio Research Center Co., Ltd. is a absolute supplier for analysis laboratories in universities and biologic industry in Japan. BRC assuredly searches for avant-garde technologies to accommodate its barter with accompaniment of the art articles from about the world. The aggregation was accustomed in 1984 and is amid in Nagoya, Japan with offices in Tokyo, Osaka and Fukuoka. Two accessory companies are anchored in the USA and in China. The aggregation currently employs 25 agents members.
IonGate Biosciences GmbH - ARTEL and IonGate Join Forces to Advance Drug Discovery Research in North America
Westbrook, ME (USA), Frankfurt / Main (Germany), 24th June, 2008. ARTEL and IonGate Biosciences appear their cardinal affiliation to abutment the growing appliance of IonGate’s biologic analysis technology. The German biotechnology aggregation will advantage ARTEL’s bounded infrastructure, chump relationships and bazaar ability to access the acknowledgment and use of its analysis systems and appraisal development casework in North America. The affiliation will focus on IonGate’s SURFE2R Technology, which enables added able analysis involving biologic targets such as film transporters and ligand-gated ion channels.
Membrane carriage proteins play an important role in abundant biological functions, and accept been affiliated to cardiac, neurologic and metabolic disorders, yet they represent a almost adopted articulation of the biologic analysis market. The antecedent abridgement of technology for able agent screening has led biologic companies to focus the majority of their analysis initiatives on added targets. Ligand-gated ion approach proteins, while added frequently targeted, about are aswell accountable to less-than-optimal screening methods. IonGate’s SURFE2R (SURFace Electrogenic Event Reader) Technology represents a cogent advanced against added able screening of transporters as able-bodied as ligand-gated ion channels.
“Transporter-focused biologic analysis initiatives are assertive for accelerated advance worldwide, and the U.S. appeal for our SURFE2R Technology is rising,” said Dr. Thiemo Gropp Ph.D., Managing Director, IonGate Biosciences GmbH. “With ARTEL’s abutment and bazaar expertise, we will be able to bear the aforementioned alone abutment to our barter in North America as we bear to our barter in Europe.”
“We chose ARTEL because of the company’s able relationships with biopharmaceutical companies, awful accomplished staff, and abysmal compassionate of our customers’ needs,” said Wolfgang Lerch, President, IonGate Biosciences Inc. “Our companies’ accessory cultures and able customer-focused orientations will acquiesce us to accompany an unparalleled aggregate of accomplished account and technology to the biologic analysis industry.”
“IonGate and ARTEL allotment a adherence to high-quality technology and above chump service. We’re aflame to be alive with a apple chic aggregation with such cutting-edge technology,” said Kirby Pilcher, President, ARTEL.
IonGate’s systems are able accoutrement for advisers in ample biologic companies as able-bodied as bookish environments. The systems are admired for amount axiological testing, early-stage screening, ADME studies, etc., and are able to accommodated the appropriate throughput. A “label-free” method, SURFE2R provides altitude assays which are added functionally relevant, and appropriately of college value, for a growing arrangement of protein targets. The affection of this technology is an electrode biochip which measures the electrical action of membrane-bound proteins. This action is empiric through altitude of the capacitive charging of the sensor cavity by ionic breed as they are actively transported above the film by the protein targets of interest.
Wolfgang Lerch
Managing Director
IonGate Biosciences GmbH
Industriepark Hoechst / Building D528
65926 Frankfurt/Main
Germany
phone+49.69.305.85 400
fax +49.69.305.85 444
email info@iongate.net
Media inquiries
Dr. Holger Bengs
Biotech Consulting
phone +49.69.619.94 273
fax +49.69.619.94 249
email info@holgerbengs.de
IonGate Biosciences develops, produces and markets avant-garde screening technologies to investigate transporters and is the common baton in this new area.
Transporters are capital for the metabolic functions of the cell, advice processing in the absolute organism, and play a axiological role in the bloom of humans. Due to their difficult beginning accessibility, transporters are underrepresented in accepted biologic screening processes. Now, IonGate’s aboriginal product, SURFE2R One, is abutting by the SURFE2R Workstation 500 to accommodate awful absolute anatomic screening of transporters in the higher-throughput biologic analysis and development environments. IonGate provides absolute arrangement solutions, encompassing disposables and reagents, consulting casework which cover the architecture of assays and customized applications, and arrangement class services.
IonGate Biosciences GmbH is a adventure basic financed biotechnology aggregation amid in Frankfurt/Main, Germany and Portland, Maine, USA. In accession to the capital financier and arch accomplice Heidelberg Innovation, the KfW holds a pale in IonGate. The aggregation was accustomed in 2000 and currently employs added than 30 staff.
Membrane carriage proteins play an important role in abundant biological functions, and accept been affiliated to cardiac, neurologic and metabolic disorders, yet they represent a almost adopted articulation of the biologic analysis market. The antecedent abridgement of technology for able agent screening has led biologic companies to focus the majority of their analysis initiatives on added targets. Ligand-gated ion approach proteins, while added frequently targeted, about are aswell accountable to less-than-optimal screening methods. IonGate’s SURFE2R (SURFace Electrogenic Event Reader) Technology represents a cogent advanced against added able screening of transporters as able-bodied as ligand-gated ion channels.
“Transporter-focused biologic analysis initiatives are assertive for accelerated advance worldwide, and the U.S. appeal for our SURFE2R Technology is rising,” said Dr. Thiemo Gropp Ph.D., Managing Director, IonGate Biosciences GmbH. “With ARTEL’s abutment and bazaar expertise, we will be able to bear the aforementioned alone abutment to our barter in North America as we bear to our barter in Europe.”
“We chose ARTEL because of the company’s able relationships with biopharmaceutical companies, awful accomplished staff, and abysmal compassionate of our customers’ needs,” said Wolfgang Lerch, President, IonGate Biosciences Inc. “Our companies’ accessory cultures and able customer-focused orientations will acquiesce us to accompany an unparalleled aggregate of accomplished account and technology to the biologic analysis industry.”
“IonGate and ARTEL allotment a adherence to high-quality technology and above chump service. We’re aflame to be alive with a apple chic aggregation with such cutting-edge technology,” said Kirby Pilcher, President, ARTEL.
IonGate’s systems are able accoutrement for advisers in ample biologic companies as able-bodied as bookish environments. The systems are admired for amount axiological testing, early-stage screening, ADME studies, etc., and are able to accommodated the appropriate throughput. A “label-free” method, SURFE2R provides altitude assays which are added functionally relevant, and appropriately of college value, for a growing arrangement of protein targets. The affection of this technology is an electrode biochip which measures the electrical action of membrane-bound proteins. This action is empiric through altitude of the capacitive charging of the sensor cavity by ionic breed as they are actively transported above the film by the protein targets of interest.
Wolfgang Lerch
Managing Director
IonGate Biosciences GmbH
Industriepark Hoechst / Building D528
65926 Frankfurt/Main
Germany
phone+49.69.305.85 400
fax +49.69.305.85 444
email info@iongate.net
Media inquiries
Dr. Holger Bengs
Biotech Consulting
phone +49.69.619.94 273
fax +49.69.619.94 249
email info@holgerbengs.de
IonGate Biosciences develops, produces and markets avant-garde screening technologies to investigate transporters and is the common baton in this new area.
Transporters are capital for the metabolic functions of the cell, advice processing in the absolute organism, and play a axiological role in the bloom of humans. Due to their difficult beginning accessibility, transporters are underrepresented in accepted biologic screening processes. Now, IonGate’s aboriginal product, SURFE2R One, is abutting by the SURFE2R Workstation 500 to accommodate awful absolute anatomic screening of transporters in the higher-throughput biologic analysis and development environments. IonGate provides absolute arrangement solutions, encompassing disposables and reagents, consulting casework which cover the architecture of assays and customized applications, and arrangement class services.
IonGate Biosciences GmbH is a adventure basic financed biotechnology aggregation amid in Frankfurt/Main, Germany and Portland, Maine, USA. In accession to the capital financier and arch accomplice Heidelberg Innovation, the KfW holds a pale in IonGate. The aggregation was accustomed in 2000 and currently employs added than 30 staff.
IonGate Biosciences GmbH - IonGate boosts business and sales efforts in the US with new funding
Frankfurt/Main (Germany), 17th September 2008. IonGate Biosciences GmbH announces the closing of a new annular of allotment amounting to EUR 1 million. The basic addition comes in as the new broker Hessen Kapital I GmbH joins in a bashful affiliation with IonGate and it will be acclimated for added amplification of the US business as able-bodied as for the access of the all-around commercialization of SURFE2R Technology (SURFace Electrogenic Event Reader).
After initializing its all-embracing business activities at the alpha of 2008, IonGate now advances on its way appear all-embracing bazaar positioning. Following the foundation of IonGate Biosciences Inc. in January, the alpha of a cooperation with the Japanese bell-ringer BRC in March and of a cardinal business affiliation with US-based aggregation ARTEL in June, IonGate’s next accomplish will follow: The aloft armamentarium will abutment IonGate’s US sales activities to accommodated the accretion appeal for the afresh launched SURFE2R Workstation 5000. Furthermore, the invested basic will advance the development of the technology belvedere and the SURFE2R artefact family.
Hessen Kapital is a armamentarium of the accompaniment of Hesse for Hessian medium-sized business to strenghten the companies’ disinterestedness base. Hessen Kapital joins as IonGate’s third investor, afterward Heidelberg Innovation and KfW.
About IonGate Biosciences GmbH
IonGate Biosciences GmbH develops, produces and markets avant-garde screening technologies to investigate transporters and is the common arch aggregation in this area.
Transporters are capital for the metabolic functions of the cell, advice processing in the absolute organism, and aswell play a axiological role in the bloom of humans. Due to their difficult beginning accessibility transporters are underrepresented in accepted biologic screening processes to date. For the aboriginal time, IonGate’s SURFE2R One and SURFE2R Workstation 500 accommodate awful absolute anatomic screening of transporters in higher-throughput and appropriately positions itself as a arch accomplice for the biologic industry. With its SURFE2R Workstation 500 IonGate has created a abstruse base for an automated and able-bodied analytic technique. The aggregation provides absolute arrangement solutions, encompassing disposables and reagents, as able-bodied as alone consulting services, which cover the architecture of customized applications.
IonGate Biosciences GmbH is a adventure basic financed biotechnology aggregation amid in Frankfurt/Main, Germany and Portland / Maine, USA. In accession to the capital financier and arch accomplice Heidelberg Innovation the KfW holds a pale in IonGate. The aggregation was accustomed in 2000 and currently employs added than 30 agents members.
Contact
Wolfgang Lerch
Managing Director
IonGate Biosciences GmbH
Industriepark Hoechst / Building D528
65926 Frankfurt/Main
Germany
phone+49.69.305.85 400
fax +49.69.305.85 444
email info@iongate.net
Wolfgang Lerch
President
IonGate Biosciences Inc.
25 Bradley Drive
Westbrook, Maine 04092-2013
U.S.A.
phone:+1.207.591.6376
fax:+1.207.591.6377
email info@iongate.net
Media inquiries
Dr. Holger Bengs
Biotech Consulting
phone +49.69.619.94 273
fax +49.69.619.94 249
email info@holgerbengs.de
After initializing its all-embracing business activities at the alpha of 2008, IonGate now advances on its way appear all-embracing bazaar positioning. Following the foundation of IonGate Biosciences Inc. in January, the alpha of a cooperation with the Japanese bell-ringer BRC in March and of a cardinal business affiliation with US-based aggregation ARTEL in June, IonGate’s next accomplish will follow: The aloft armamentarium will abutment IonGate’s US sales activities to accommodated the accretion appeal for the afresh launched SURFE2R Workstation 5000. Furthermore, the invested basic will advance the development of the technology belvedere and the SURFE2R artefact family.
Hessen Kapital is a armamentarium of the accompaniment of Hesse for Hessian medium-sized business to strenghten the companies’ disinterestedness base. Hessen Kapital joins as IonGate’s third investor, afterward Heidelberg Innovation and KfW.
About IonGate Biosciences GmbH
IonGate Biosciences GmbH develops, produces and markets avant-garde screening technologies to investigate transporters and is the common arch aggregation in this area.
Transporters are capital for the metabolic functions of the cell, advice processing in the absolute organism, and aswell play a axiological role in the bloom of humans. Due to their difficult beginning accessibility transporters are underrepresented in accepted biologic screening processes to date. For the aboriginal time, IonGate’s SURFE2R One and SURFE2R Workstation 500 accommodate awful absolute anatomic screening of transporters in higher-throughput and appropriately positions itself as a arch accomplice for the biologic industry. With its SURFE2R Workstation 500 IonGate has created a abstruse base for an automated and able-bodied analytic technique. The aggregation provides absolute arrangement solutions, encompassing disposables and reagents, as able-bodied as alone consulting services, which cover the architecture of customized applications.
IonGate Biosciences GmbH is a adventure basic financed biotechnology aggregation amid in Frankfurt/Main, Germany and Portland / Maine, USA. In accession to the capital financier and arch accomplice Heidelberg Innovation the KfW holds a pale in IonGate. The aggregation was accustomed in 2000 and currently employs added than 30 agents members.
Contact
Wolfgang Lerch
Managing Director
IonGate Biosciences GmbH
Industriepark Hoechst / Building D528
65926 Frankfurt/Main
Germany
phone+49.69.305.85 400
fax +49.69.305.85 444
email info@iongate.net
Wolfgang Lerch
President
IonGate Biosciences Inc.
25 Bradley Drive
Westbrook, Maine 04092-2013
U.S.A.
phone:+1.207.591.6376
fax:+1.207.591.6377
email info@iongate.net
Media inquiries
Dr. Holger Bengs
Biotech Consulting
phone +49.69.619.94 273
fax +49.69.619.94 249
email info@holgerbengs.de
订阅：
博文 (Atom)